Vanguard Group’s DiaMedica Therapeutics DMAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.99M | Buy |
|
|||||
|
2025
Q1 | $5.12M | Buy |
|
|||||
|
2024
Q4 | $6.74M | Buy |
|
|||||
|
2024
Q3 | $4.4M | Buy |
|
|||||
|
2024
Q2 | $3M | Buy |
|
|||||
|
2024
Q1 | $2.81M | Buy |
|
|||||
|
2023
Q4 | $2.28M | Buy |
|
|||||
|
2023
Q3 | $2.04M | Buy |
|
|||||
|
2023
Q2 | $3.38M | Hold |
|
|||||
|
2023
Q1 | $1.2M | Hold |
|
|||||
|
2022
Q4 | $1.24M | Buy |
|
|||||
|
2022
Q3 | $971K | Hold |
|
|||||
|
2022
Q2 | $1.58M | Hold |
|
|||||
|
2022
Q1 | $1.96M | Sell |
|
|||||
|
2021
Q4 | $2.93M | Sell |
|
|||||
|
2021
Q3 | $3.16M | Buy |
|
|||||
|
2021
Q2 | $3.5M | Sell |
|
|||||
|
2021
Q1 | $7.74M | Buy |
|
|||||
|
2020
Q4 | $7.91M | Buy |
|
|||||
|
2020
Q3 | $1.45M | Buy |
|
|||||
|
2020
Q2 | $1.68M | Sell |
|
|||||
|
2020
Q1 | $677K | Buy |
|
|||||
|
2019
Q4 | $393K | Hold |
|
|||||
|
2019
Q3 | $166K | Buy |
|
|||||
|
2019
Q2 | $170K | Buy |
|